siRNA, Anti-PRDM6, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51613WQ-2OMe)

The product SIRGT51613WQ-2OMe is a type of small interfering RNA (siRNA) that targets PRDM6 gene and regulates the expression of gene. The siRNA interferes with the expression of PRDM6 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001136239.3
Alternative Names KMT8C; PDA3; PRISM
Related Diseases Patent Ductus Arteriosus 3
Purification HPLC
Target Gene
Gene ID 93166
Uniprot ID Q9NQX0
Sub Cat Target Species Modification Scale  
SIRGT52613WQ-2F PRDM6 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53613WQ-2MOE PRDM6 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54613WQ-LNA PRDM6 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT91911WQ-2OMe Prdm6 Mouse 2ʹ-O-methyl (2'-OMe) Inquiry
SIRGT92911WQ-2F Prdm6 Mouse 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT93911WQ-2MOE Prdm6 Mouse 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT94911WQ-LNA Prdm6 Mouse Locked Nucleic Acid (LNA) Inquiry
SIRGT51613WQ-RB PRDM6 Human Ribo-modified Inquiry
SIRGT52613WQ-BB PRDM6 Human Backbone-modified Inquiry

Related Products